Clinical Characteristics, Prognostic Factors and Therapeutic Strategies in Gastric Cancer Patients With Bone Metastasis: A Retrospective Analysis
Our results suggest bone-metastatic GC patients exhibit distinct clinicopathological features, with a high incidence of bone metastasis in PCC. Immunotherapy-based combination therapies offer improved survival benefits, thus supporting the application of immunotherapy in GC patients at high risk of bone metastasis.
Authors
- Baorui Liu (ORCID: https://orcid.org/0000-0002-2539-7732)
- Yipeng Zhang (ORCID: https://orcid.org/0000-0003-2411-5390)
- Wenqi Liu (ORCID: https://orcid.org/0000-0002-9359-5589)
- Yue Wang
- Jia Wei (ORCID: https://orcid.org/0000-0003-3024-8878)
- Ju Yang (ORCID: https://orcid.org/0000-0001-5305-7893)
- Yutao Wei (ORCID: https://orcid.org/0000-0001-8738-0488)
- Tao Shi (ORCID: https://orcid.org/0000-0002-9825-3983)
- S. Ren (ORCID: https://orcid.org/0009-0003-1201-1452)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Drum Tower Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/cam4.70781
- Primary Topic
- Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Jiangsu Province